Lonza Group AG
LONN
Rank in Stocks
#449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Share Price
$761.37
Market Cap
$53.18B
Change (1 day)
0.61%
Change (1 year)
8.22%
Country
CH
Trade Lonza Group AG (LONN)
Category
Healthcare
P/S ratio for Lonza Group AG (LONN)
P/S ratio as of 2026 TTM: 0
According to Lonza Group AG latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Lonza Group AG from 2004 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2025 | 5.77 | -0.67% |
| 2024 | 5.80 | 49.68% |
| 2023 | 3.88 | -28.25% |
| 2022 | 5.40 | -48.31% |
| 2021 | 10.46 | 11.37% |
| 2020 | 9.39 | 50.88% |
| 2019 | 6.22 | 81.59% |
| 2018 | 3.43 | -12.81% |
| 2017 | 3.93 | 88.09% |
| 2016 | 2.09 | -0.13% |
| 2015 | 2.09 | 40.40% |
| 2014 | 1.49 | 30.83% |
| 2013 | 1.14 | 70.33% |
| 2012 | 0.67 | -37.18% |
| 2011 | 1.06 | -27.38% |
| 2010 | 1.47 | 6.38% |
| 2009 | 1.38 | -21.31% |
| 2008 | 1.75 | -30.69% |
| 2007 | 2.53 | 0.33% |
| 2006 | 2.52 | 66.67% |
| 2005 | 1.51 | 8.72% |
| 2004 | 1.39 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 4.19 | - |
AU
|
|
| 10.44 | - |
NL
|
|
| 4.52 | - |
BE
|
